Cargando…
Survival Analysis of Antineoplastic Treatment for Older Patients with Metastatic Non-Small-Cell Lung Cancer: A Clinical Database Study
PURPOSE: To explore whether antineoplastic treatment can improve overall survival (OS) in older patients with metastatic non-small-cell lung cancer (mNSCLC). PATIENTS AND METHODS: Using the cancer registry database of a tertiary medical center in Taiwan, we followed patients 65 years old and above w...
Autores principales: | Yu, Chin-Hsiu, Cheng, Ya-Ai, Chen, Ru-Yih, Wu, Yu-Lung, Lin, Min-Hsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755879/ https://www.ncbi.nlm.nih.gov/pubmed/33376393 http://dx.doi.org/10.2147/CMAR.S282481 |
Ejemplares similares
-
Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer
por: Ryssel, Heidi, et al.
Publicado: (2022) -
Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
por: Wang, Yan, et al.
Publicado: (2023) -
Evidence for tankyrases as antineoplastic targets in lung cancer
por: Busch, Alexander M, et al.
Publicado: (2013) -
Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
por: Campos‐Balea, Begoña, et al.
Publicado: (2020) -
A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases
por: Chen, Yu-Mu, et al.
Publicado: (2016)